# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058744
Filing Date
2024-05-13
Accepted
2024-05-13 16:44:27
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | calc-20240331.htm iXBRL | 10-Q | 2099734
2 | EX-31.1 | calc-ex31_1.htm | EX-31.1 | 14328
3 | EX-31.2 | calc-ex31_2.htm | EX-31.2 | 14577
4 | EX-32.1 | calc-ex32_1.htm | EX-32.1 | 9476
5 | EX-32.2 | calc-ex32_2.htm | EX-32.2 | 8858
| Complete submission text file | 0000950170-24-058744.txt |  | 7783673

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | calc-20240331.xsd | EX-101.SCH | 1256128
63 | EXTRACTED XBRL INSTANCE DOCUMENT | calc-20240331_htm.xml | XML | 1064692

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39538 | Film No.: 24939819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)